Gaois

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

5 results

  2. SOCIAL QUESTIONS|health|illness · SOCIAL QUESTIONS|health|medical science

    #620636

    IATE #1142661
    liomfóma neamh-Hodgkin Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Nicht-Hodgkin-Lymphom | Non-Hodgkin-Lymphom | NHL
    de
    non-Hodgkin's lymphoma | NHL
    en
    Definition The non-Hodgkin's lymphomas are the single largest group of neoplasms of the immune system. Composed of more than ten distinct disease entities (among them, Burkitt's lymphoma, adult T cell leukaemia), the non-Hodgkin's lymphomas are best understood as a heterogeneous group of malignant diseases whose common link is a characteristic monoclonal expansion of B or T lymphocytesThere are two main types of non-Hodgkin lymphomas: a) low grade non-Hodgkin's lymphoma and b) high grade non-Hodgkin's lymphoma. Reference "Based on: Cancer Research UK http://www.cancerhelp.org.uk/help/default.asp?page=13300#group [23.1.2008]"
    Comment "This category no longer exists in the new WHO classification and the REAL classificationSee also: a) revised WHO classification: http://www.pathology.ucla.edu/educ/lecture/pathrev/lymphoma.htm [23.1.2008] andb) The Revised European-American Classification of Lymphoid Neoplasms (REAL classification) http://www.cancer.med.umich.edu/news/moj00fa4.shtml [23.1.2008] and Lymphoma Information Network http://www.lymphomainfo.net/nhl/classify-older.html [23.1.2008]"
    LNH | lymphome non-hodgkinien | lymphome non hodgkinien
    fr
    Definition groupe extrêmement hétérogène de néoplasies lymphoïdes définies en fait de manière négative par l'exclusion des leucemies lymphoïdes aigues et pour certaines chroniques de la maladie de Hodgkin et des proliférations lymphoïdes avec d'immunoglobulines Reference GLTM
  3. SOCIAL QUESTIONS|health|illness

    #602793

    IATE #210197
    liomfóma neamh-Hodgkin leasc Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    liomfóma neamh-Hodgkin mallfháis Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Non-Hodgkin-Lymphom von niedrigem Malignitätsgrad | NHL-NM | Non-Hodgkin-Lymphome niedriger Malignität
    de
    low-grade non-Hodgkin's lymphoma | indolent non-Hodgkin's lymphoma | slow-growing non-Hodgkin's lymphoma
    en
    Definition slow growing form of lymphoma Reference "Lymphoma Information Network > Lymphoma Info > Indolent Non-Hodgkin's Lymphomas, http://www.lymphomainfo.net/nhl/indolent.html (7.8.2009)"
    Comment Indolent NHLs have traditionally not been strongly responsive to conventional cancer therapies such as chemotherapy and radiation therapy.
    lymphome non hodgkinien de faible degré de malignité | lymphome non hodgkinien indolent | lymphome non hodgkinien de faible malignité
    fr
    Definition catégorie de lymphomes non hodgkiniens à petites cellules (centrocytiques, lymphocytiques et lymphoplasmocytaires) qu'ils soient de structures nodulaire ou diffuse, d'évolution lente, le plus souvent disséminés à la moelle osseuse (stade IV) Reference Marie, J.-P., Lymphomes non hodgkiniens, Impact internat, n° 5, 01/90, p.176
  4. SOCIAL QUESTIONS|health|illness · SOCIAL QUESTIONS|health|medical science

    #640405

    IATE #2245894
    liomfóma neamh-Hodgkin ionsaitheach Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    NHL-HM | Non-Hodgkin-Lymphome hoher Malignität
    de
    aggressive non-Hodgkin's lymphoma | fast-growing non-Hodgkin's lymphoma | high-grade non-Hodgkin's lymphoma
    en
    Definition fast growing form of lymphoma Reference "Lymphoma Information Network > Lymphoma Info > Aggressive Non-Hodgkin's Lymphoma, http://www.lymphomainfo.net/nhl/aggressive.html (7.8.2009)"
    Comment Aggressive NHLs are generally responsive to conventional cancer therapies such as chemotherapy and radiation therapy.